Sareum Holdings (SAR) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 Mar 2005 07:00 AM
RNS
Rule 2.10 Announcement
04 Mar 2005 07:00 AM
RNS
Statement re speculation
15 Dec 2004 07:00 AM
RNS
Collaboration
06 Dec 2004 07:00 AM
RNS
New Cancer Collaboration
03 Dec 2004 04:14 PM
RNS
Shareholding
01 Dec 2004 07:00 AM
RNS
Drug Discovery Collaboration
29 Nov 2004 02:13 PM
RNS
Holding(s) in Company
22 Nov 2004 07:00 AM
RNS
Collaboration Agreement
15 Nov 2004 11:56 AM
RNS
Holding(s) in Company
09 Nov 2004 07:00 AM
RNS
Collaborative Agreement
26 Oct 2004 05:29 PM
RNS
Holding(s) in Company
11 Oct 2004 07:00 AM
RNS
First day of dealings on AIM

Sareum is a clinical-stage drug discovery and development company that produces targeted small-molecule therapeutics for treating cancer and autoimmune diseases.

The drug research programs of the company are based on its proprietary drug discovery technology. The company delivers drug candidates for licensing to biotechnology and pharmaceutical companies at the pre-clinical or early clinical trials stage. 

SAR share price listed on AIM in 2004 under the ticker SAR.

UK 100

Latest directors dealings